Deferred Tax Assets, Operating Loss Carryforwards of Mosaic ImmunoEngineering Inc. from 31 May 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Mosaic ImmunoEngineering Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 May 2013 to 31 Dec 2024.
  • Mosaic ImmunoEngineering Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $685,824, a 55% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Mosaic ImmunoEngineering Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $685,824 +$243,549 +55% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $442,275 -$62,670 -12% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $504,945 +$132,433 +36% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q4 2021 $372,512 +$275,539 +284% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q4 2020 $96,973 31 Dec 2020 10-K 26 Jan 2022 2021 FY
Q2 2020 $0 -$7,330,976 -100% 31 May 2020 10-KT 02 Mar 2021 2020 FY
Q2 2019 $7,330,976 +$212,077 +3% 31 May 2019 10-K 24 Aug 2020 2020 FY
Q2 2018 $7,118,899 -$2,878,233 -29% 31 May 2018 10-K 29 Aug 2019 2019 FY
Q2 2017 $9,997,132 -$255,468 -2.5% 31 May 2017 10-K 29 Aug 2018 2018 FY
Q2 2016 $10,252,600 +$542,645 +5.6% 31 May 2016 10-K 29 Aug 2017 2017 FY
Q2 2015 $9,709,955 +$553,528 +6% 31 May 2015 10-K 29 Aug 2016 2016 FY
Q2 2014 $9,156,427 -$335,550 -3.5% 31 May 2014 10-K 31 Aug 2015 2015 FY
Q2 2013 $9,491,977 31 May 2013 10-K 19 Aug 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.